Work

T.P.45 An ongoing phase 2a study to investigate drug–drug interactions between escalating doses of AT2220 (duvoglustat hydrochloride) and acid alpha glucosidase in subjects with Pompe disease – Preliminary results

Year: 2012

Type: article

Study design: Clinical Trial

Source: Neuromuscular Disorders

DOI: 10.1016/j.nmd.2012.06.164

Authors: P. Kishnani, M. Tarnopolsky, K. Sivakumar, B. Byrne, O. Goker-Alpan, K. Guter, M. Pervaiz, M. Dasouki, T. Levine, M. Roberts, F.K. Johnson, S. Sitaraman, R. Khanna, J. Flanagan, E.R. Sjoberg, K.J. Valenzano, D.J. Lockhart, P. Boudes

Institutions: Duke Medical Center, McMaster University, University of Florida Health, University of Florida, Great Falls Clinic, Emory University, University of Kansas Medical Center, Phoenix Neurological Associates, Salford Royal Hospital, Amicus Therapeutics (United States)

Language: English

Topic: Lysosomal Storage Disorders Research

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1970820682

FWCI: 0.481

Cites:

Cited by: 3

Related to: 10